Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

1.0K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
1.0K
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

3.7K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
3.7K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

1.1K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.1K
Lipid Absorption01:24

Lipid Absorption

2.0K
Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
2.0K
Lipids: Dietary Sources and Requirements01:18

Lipids: Dietary Sources and Requirements

1.5K
Lipids are an essential component of a balanced human diet. Triglycerides, which make up the majority of dietary lipids, are found in both saturated fats—commonly present in meat, dairy products, and certain tropical plants like coconut, and hydrogenated oils such as margarine and baking shortenings (trans fats)—and unsaturated fats, which are abundant in seeds, nuts, olive oil, and most vegetable oils. The main sources of cholesterol include egg yolks, various meats and organ...
1.5K
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

425
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
425

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Casual alcohol consumption is associated with less subclinical cardiovascular organ damage in Koreans: a cross-sectional study.

BMC public health·2018
Same author

The SCAP/SREBP Pathway: A Mediator of Hepatic Steatosis.

Endocrinology and metabolism (Seoul, Korea)·2017
Same journal

Oxidative stress drives liver failure during in vivo partial reprogramming.

Molecules and cells·2026
Same journal

scpp5 regulates tooth development and injury-induced repair in zebrafish through mineralization and Wnt/β-catenin signaling.

Molecules and cells·2026
Same journal

Corrigendum to "Molecular role of developmentally regulated GTP-binding protein 1 in coordinating osteoclast and osteoblast differentiation during bone remodeling" [Mol. Cells 49 (2026) 100342].

Molecules and cells·2026
Same journal

Multiple ShKT domain-containing MUL-1 proteins act as redox-responsive modulators of oxidative stress signaling in C. elegans.

Molecules and cells·2026
Same journal

Small molecule inhibition of voltage dependent anion channel 1 reroutes mitochondrial metabolite flux.

Molecules and cells·2026
Same journal

Adherent-to-suspension transition modulates circulating tumor cell dynamics and metastatic potential in melanoma.

Molecules and cells·2026
See all related articles

Related Experiment Video

Updated: Nov 15, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

16.4K

Increased Hepatic Lipogenesis Elevates Liver Cholesterol Content.

Jean-Mathieu Berger1, Young-Ah Moon2

  • 1Departments of Internal Medicine and Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Molecules and Cells
|March 4, 2021
PubMed
Summary
This summary is machine-generated.

Nonalcoholic fatty liver disease (NAFLD) increases cardiovascular disease risk. This study shows that increased fatty acid synthesis in the liver, not cholesterol synthesis, drives dyslipidemia in NAFLD by altering cholesterol metabolism and excretion.

Keywords:
cholesteroldyslipidemiafatty liverlipogenesis

More Related Videos

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
07:12

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

Published on: June 2, 2023

8.0K
Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.4K

Related Experiment Videos

Last Updated: Nov 15, 2025

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
08:58

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis

Published on: March 11, 2017

16.4K
Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment
07:12

Author Spotlight: Analysis of Fluorescent-Stained Lipid Droplets with 3D Reconstruction for Hepatic Steatosis Assessment

Published on: June 2, 2023

8.0K
Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

4.4K

Area of Science:

  • Metabolic disease research
  • Hepatology
  • Cardiovascular science

Background:

  • Cardiovascular diseases (CVDs) are the leading cause of death in nonalcoholic fatty liver disease (NAFLD) patients.
  • Dyslipidemia is a key factor contributing to elevated CVD risk in NAFLD.

Purpose of the Study:

  • To investigate how hepatic de novo lipogenesis impacts liver cholesterol content.
  • To determine the effects of hepatic lipogenesis on plasma lipid levels in NAFLD models.

Main Methods:

  • Mice were fed a fat-free/high-sucrose (FF/HS) diet to induce hepatic lipogenesis.
  • Analysis of metabolic pathways related to cholesterol homeostasis.
  • Assessment of very low-density lipoprotein (VLDL) secretion in Ldlr-/- mice.

Main Results:

  • FF/HS diet significantly increased liver triglyceride and cholesterol content.
  • Increased fatty acid synthesis, via sterol regulatory element binding protein (SREBP)-1c activation, elevated liver triglycerides.
  • Liver cholesterol accumulation resulted from reduced bile acid and fecal cholesterol excretion, and increased plasma lipoprotein uptake, despite decreased cholesterol synthesis.
  • Increased VLDL secretion led to hypertriglyceridemia and hypercholesterolemia in Ldlr-/- mice.

Conclusions:

  • Hepatic de novo lipogenesis plays a critical role in NAFLD-associated dyslipidemia.
  • Hypercholesterolemia in NAFLD is not solely explained by dietary cholesterol or synthesis rates.
  • Targeting fatty acid synthesis may be crucial for managing dyslipidemia in NAFLD patients.